#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA976885	F	Cytotoxicity against human SNU449 cells expressing wild type EGFR at 2 uM assessed as fraction of viable cells after 72 hrs relative to control	Homo sapiens	2	ALA1149823	cell-based format	Scientific Literature
2.	ALA970348	F	Cytotoxicity against human SNU449 cells assessed as fraction of viable cells after 72 hrs relative to control	Homo sapiens	10	ALA1149823	cell-based format	Scientific Literature
3.	ALA977035	F	Cytotoxicity against human SNU449 cells expressing wild type BRAF at 0.2 uM assessed as fraction of viable cells after 72 hrs relative to control	Homo sapiens	1	ALA1149823	cell-based format	Scientific Literature
4.	ALA977036	F	Cytotoxicity against human SNU449 cells expressing wild type BRAF at 2 uM assessed as fraction of viable cells after 72 hrs relative to control	Homo sapiens	1	ALA1149823	cell-based format	Scientific Literature
5.	ALA1943532	F	Cytotoxicity against human SNU449 cells at 50 uM after 48 hrs	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
6.	ALA1943533	F	Cytotoxicity against human SNU449 cells at 50 uM after 72 hrs	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
7.	ALA1943534	F	Cytotoxicity against human SNU449 cells after 48 hrs	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
8.	ALA1943535	F	Cytotoxicity against human SNU449 cells after 72 hrs	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
9.	ALA1943636	F	Cell cycle arrest in human SNU449 cells assessed as accumulation at G1 phase at 25 uM after 48 to 72 hrs using annexin V/propidium iodide staining by flow cytometric analysis	Homo sapiens	1	ALA1938375	cell-based format	Scientific Literature
10.	ALA1943637	F	Cell cycle arrest in human SNU449 cells assessed as accumulation at G1 phase at 50 uM after 72 hrs using annexin V/propidium iodide staining by flow cytometric analysis	Homo sapiens	1	ALA1938375	cell-based format	Scientific Literature
11.	ALA1942313	F	Cell cycle arrest in human SNU449 cells assessed as accumulation at G1 phase at 100 uM after 48 to 72 hrs using annexin V/propidium iodide staining by flow cytometric analysis	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
12.	ALA1942314	F	Cell cycle arrest in human SNU449 cells assessed as accumulation at S phase at 100 uM after 48 to 72 hrs using annexin V/propidium iodide staining by flow cytometric analysis	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
13.	ALA1942315	F	Decrease of cyclin D1 level in human SNU449 cells at 50 uM after 72 hrs by Western blotting relative to beta-actin	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
14.	ALA1942316	F	Effect on p27 expression in human SNU449 cells at 50 uM after 72 hrs by Western blotting relative to beta-actin	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
15.	ALA1942317	F	Up-regulation of p21 expression in human SNU449 cells at 50 uM after 72 hrs by Western blotting relative to beta-actin	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
16.	ALA1942318	F	Up-regulation of p53 expression in human SNU449 cells at 50 uM after 72 hrs by Western blotting relative to beta-actin	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
17.	ALA1942321	F	Induction of apoptosis in human SNU449 cells at 50 to 100 uM after 72 hrs using annexin V/propidium iodide staining by flow cytometric analysis	Homo sapiens	2	ALA1938375	cell-based format	Scientific Literature
18.	ALA2032766	F	Antiproliferative activity against human SNU449 after 72 hrs by CellTiter Glo assay	Homo sapiens	5	ALA2029236	cell-based format	Scientific Literature
19.	ALA2175188	F	Cytotoxicity against human SNU449 cells with intact TGFbeta pathway assessed as growth inhibition at 250 uM after 72 hrs by MTT assay	Homo sapiens	1	ALA2169778	cell-based format	Scientific Literature
20.	ALA2363668	F	SANGER: Inhibition of human SNU-449 cell growth in a cell viability assay.	Homo sapiens	97	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer